1.
KHAN MA, SOMWANSHI SB, VADITAKE KT, KOTADE KB. QBD-DRIVEN DESIGN AND PHARMACOKINETIC PROFILING OF REMOGLIFLOZIN ETABONATE SUSTAINED-RELEASE MATRIX TABLETS FOR DIABETES MANAGEMENT. Int J App Pharm [Internet]. 2025 Oct. 30 [cited 2025 Dec. 5];18(1). Available from: https://www.journals.innovareacademics.in/index.php/ijap/article/view/56445